ArticleBiologics : targets & therapy2018

Combination of EGFR-TKIs with chemotherapy versus chemotherapy or EGFR-TKIs alone in advanced NSCLC patients with EGFR mutation.

Miaomiao Wen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.